Both GM and Honda have more than 1,200 fuel cell patents between them, filed between 2002 and 2012, and experimental vehicle fleets. They are the top two companies in terms of total fuel cell patents according to the Clean Energy Patent Growth Index.
Both companies aim to develop the vehicles by 2020. The alliance will bring down their costs in building this expensive technology by sharing each other�� expertise and suppliers.
Why Fuel Cell Vehicles?
The U.S. mandate requires corporate average fuel economy of 54.5 miles per gallon by 2020 and there is no better competent than fuel cell vehicles. Why? Fuel cells have highly fuel-efficient technology compared to gasoline and electric batteries. Secondly, it has a longer driving range (up to 400 miles) than electric cars but pollutes less than gasoline vehicles.
Top 10 Clean Energy Stocks To Own Right Now: AEterna Zentaris Inc.(AEZS)
Aeterna Zentaris Inc. operates as a late-stage drug development company specialized in oncology and endocrine therapy. Its lead oncology compounds include perifosine, a PI3K/Akt pathway inhibitor that is in Phase 3 registration trial for refractory advanced colorectal cancer and multiple myeloma; and AEZS-108, a doxorubicin-targeted conjugate in Phase II for the treatment of ovarian, endometrial, castration refractory prostate, and refractory bladder cancer. The company?s lead endocrinology compound, AEZS-130, is an oral ghrelin antagonist in Phase III trial as a diagnostic test for adult growth hormone deficiency. Its pipeline also includes earlier-stage compounds, such as AEZS-112 that is in a Phase I trial in advanced solid tumors and lymphoma, as well as AEZS-120, an anti-cancer vaccine in pre-clinical development. The company was founded in 1991 and is headquartered in Quebec City, Canada.
Advisors' Opinion:- [By Sean Williams]
What's coming down the pipeline
Avastin: Surprise: It's Roche's (NASDAQOTH: RHHBY ) wonder drug yet again! Roche's Avastin is in the process of being tested as a treatment for recurrent endometrial cancer and demonstrated promising results in a mid-stage trial according to the Journal of Clinical Oncology. Avastin, which is an angiogenesis inhibitor (a fancy way of saying it inhibits blood vessel growth), was tested on 52 evaluable patients and delivered a progression-free survival of at least six months for 21 of them. Overall median PFS was 4.2 months, and median overall survival came in at 10.5 months. Don't be surprised if Roche decides to pursue further studies of Avastin in recurrent endometrial cancer with these results.� AEZS-108: Currently in late-stage development by Aeterna Zentaris (NASDAQ: AEZS ) , a holding in my own portfolio, AEZS-108 is an intravenous treatment composed of a synthetic peptide carrier and doxorubicin that targets Luteinizing Hormone Releasing Hormone-receptor expressing tumors. That series of scientific jargon simply means it targets cancer cells with minimal healthy cell death relative to the current standards of treatment. In mid-stage trials, AEZS-108 delivered an overall response rate of 30.8% and a clinical benefit rate of 74.4%. These figures were enough to get AEZS-108 a special protocol assessment (SPA), which should streamline its approval if these results stay consistent in late-stage studies.
As we saw with the current treatment options, the endometrial cancer pipeline isn't filled with a lot of choices, but they are at least more encouraging than the standard care treatments we've seen over the past three decades.Your best investment
With very few investable options to choose from, since many of these treatments are off patent as they're decades old, I'm going to split my decision this week between Roche and Aeterna Zentaris for obvious reasons. - [By Sean Williams]
High-risk, high-reward suggestions
Exelixis (NASDAQ: EXEL ) : In November Exelixis had its first drug, known as Cometriq, approved by the Food and Drug Administration to treat metastatic medullary thyroid cancer. Although the market for this disease is pretty small -- somewhere between 500 and 700 people in the U.S. -- the near-tripling in progression-free survival, or PFS, in trials would indicate to me a strong likelihood that it could translate to success in other cancer types. In mid-stage prostate cancer trials, for instance, Cometriq was found to be particularly effective in dealing with bone metastases as a second or third-line treatment. We won't get any additional data until next year on Cometriq, but positive data on the prostate cancer front could be enough to double its share price if the PFS, compared to the placebo, is notably strong. ImmunoGen (NASDAQ: IMGN ) : In February, Roche�and ImmunoGen received approval for Kadcyla as a secondary treatment for HER2-positive breast cancer. This is ImmunoGen's first drug approval, and it gives the company a chance to showcase what I feel is one of the future pathways of fighting cancer -- its targeted-antibody payload, or TAP, technology. ImmunoGen's TAP technology works by attaching a toxin -- in this case Roche's Herceptin -- to an antibody, and teaching that antibody to release the to
There's an undeniably large dollar amount being pledged to cancer research, but, even if a drug gains approval, that's no guarantee that the biotech or pharmaceutical company behind that drug will be a success. Some of the biggest gains (and losses) come from taking a leap of faith based on clinical data, or the approval of one or two drugs or devices within a pipeline. After that, it's all up to the drug or devices' effectiveness, its pricing, and the success of the marketing teams promoting the drug or device. Here are a few high-risk, high-reward names you should be keeping your eye on. - [By Eric Volkman]
Aeterna Zentaris (NASDAQ: AEZS ) has made a significant change in its executive suite and boardroom. David Dodd is now the company's chief executive and a member of its board of directors. He succeeds Juergen Engel. The firm did not provide the reasons for the succession.
Top 10 Clean Energy Stocks To Own Right Now: Univest Corporation of Pennsylvania(UVSP)
Univest Corporation of Pennsylvania, through its subsidiaries, provides various financial solutions, including personal and business banking, online banking, residential mortgages, insurance products, and investment and wealth advisory solutions. It serves the financial needs of residents, businesses, and nonprofit organizations in Bucks, Chester, Montgomery, and Lehigh counties, Pennsylvania. The company accepts various deposit products that include non interest-bearing demand deposits, interest-bearing checking deposits, money market savings accounts, regular savings accounts, and time deposits. Its loan and lease portfolio comprises commercial, financial, and agricultural loans and leases; commercial and construction loans; residential loans; loans to individuals; and municipal loans and leases. Univest Corporation also offers lease financing, financial planning, investment management, insurance products, and brokerage services; and provides investment advisory services , which include discretionary investment consulting and management services, as well as engages in small ticket commercial finance business. It provides its services through 32 financial service centers, 12 retirement financial services centers, and 39 ATM locations. The company was founded in 1973 and is headquartered in Souderton, Pennsylvania.
Best Low Price Companies To Own For 2014: Phytopharm(PYM.L)
Phytopharm plc, a development stage pharmaceutical company, develops novel treatments targeting diseases with high levels of unmet need. The company?s lead compounds include Cogane and Myogane, which are orally bioavailable neurotrophic factor modulators that readily cross the blood brain barrier. Its Cogane is in Phase II clinical trials for the treatment of early stage Parkinson?s disease. The company?s Cogane and Myogane compounds are also in various preclinical stages for the treatment of Parkinson?s disease, amyotrophic lateral sclerosis, glaucoma, and Alzheimer?s disease. In addition, it focuses on developing PYM60001, a pharmaceutical medicine for the treatment of chronic obstructive pulmonary disease, asthma, atopic dermatitis, psoriasis, gastrointestinal inflammatory conditions, and pain; and Hoodia for the management of obesity. The company has operations in Europe, the United Kingdom, Asia, South Africa, and the United States. Phytopharm plc is based in Hun tingdon, the United Kingdom.
Top 10 Clean Energy Stocks To Own Right Now: Aquarius Platinum Ld(AQP.L)
Aquarius Platinum Limited engages in the acquisition, exploration, and development of platinum group metal (PGM) projects, and mining of PGM. It explores primarily for platinum, palladium, rhodium, and gold. The company owns interests in seven operations that are located on the Bushveld Complex in South Africa and the Great Dyke in Zimbabwe. Its primary operation is the Kroondal Mine, situated on the Western Limb of the Bushveld Complex in North West province of South Africa. The company is based in Hamilton, Bermuda.
Top 10 Clean Energy Stocks To Own Right Now: The Herzfeld Caribbean Basin Fund Inc. (CUBA)
Herzfeld Caribbean Basin Fund Inc. is a closed-ended equity mutual fund launched by Thomas J. Herzfeld Advisors, Inc. The fund is managed by Herzfeld/Cuba. It invests in the public equity markets of the Caribbean Basin Countries and the United States. The fund makes its investments in stocks of companies operating across diversified sectors. Herzfeld Caribbean Basin Fund Inc. was formed on March 10, 1992 and is domiciled in the United States.
Top 10 Clean Energy Stocks To Own Right Now: Cobar Consolidated Resources Ltd(CCU.AX)
Cobar Consolidated Resources Limited engages in the exploration and development of base and precious metals in Australia. It has 1,371 square kilometers of tenement interests on the western margin of the Cobar basin in western New South Wales. The company primarily focuses on developing the Wonawinta silver project in the Cobar basin in western New South Wales. It also has exploration projects, including the Gundaroo project, the Winduck Super project, the McKinnons gold deposit, and the Goldwing project. The company is based in Melbourne, Australia.
Top 10 Clean Energy Stocks To Own Right Now: Fisher Communications Inc.(FSCI)
Fisher Communications, Inc., an integrated media company, through its subsidiaries, engages in television and radio broadcasting businesses. The company owns and operates network-affiliated television stations in Washington, Oregon, Idaho, and California, as well as engages in Internet business; and radio stations and managed radio stations in Washington and Montana. It also owns and operates Fisher Plaza, a commercial building that includes a data center designed to enable companies to distribute analog and digital media content through various distribution channels, including broadcast, satellite, cable, Internet, broadband, and other wired and wireless communication systems, as well as houses various companies, including media and communications companies. The company owns and operates 13 full power television stations, 7 low power television stations, and 10 owned and managed radio stations in the Western United States. Its television stations reach 4.2 million househo lds. The company was formerly known as Fisher Companies, Inc. and changed its name in March 2001. Fisher Communications, Inc. was founded in 1910 and is based in Seattle, Washington.
Advisors' Opinion:- [By Eric Volkman]
In the latest of a string of acquisitions, Sinclair Broadcast Group (NASDAQ: SBGI ) is to buy Fisher Communications (NASDAQ: FSCI ) . The merger transaction will cost the former roughly $373 million. Fisher stockholders are to receive a cash payout of $41.00 per share, which, according to Sinclair, is a 44% premium to the stock's recent closing price.
Top 10 Clean Energy Stocks To Own Right Now: Forest Place Group Ltd(FPG.AX)
Forest Place Group Limited engages in the ownership, development, and operation of retirement villages and residential aged care facilities (nursing homes) in south-east Queensland, Australia. The company?s portfolio comprises five retirement villages located in Albany Creek, Clayfield, Cleveland, Durack, and Taringa. It leases and re-leases 102 accommodation units in its owned retirement villages. The company is based in Brisbane, Australia.
Top 10 Clean Energy Stocks To Own Right Now: John B. Sanfilippo & Son Inc.(JBSS)
John B. Sanfilippo & Son, Inc. engages in the processing and marketing of tree nuts and peanuts in the United States. It offers raw and processed nuts, including peanuts, almonds, Brazil nuts, pecans, pistachios, filberts, cashews, English walnuts, black walnuts, pine nuts, and macadamia nuts. The company provides nut products in various styles and seasonings, such as natural, blanched, oil roasted, dry roasted, unsalted, honey roasted, flavored, spicy, butter toffee, praline, and cinnamon toasted. It also offers peanut butter; food and snack products comprising snack mixes, salad toppings, natural snacks, trail mixes, dried fruit, and chocolate and yogurt coated products; baking ingredients; bulk food products; sunflower seeds, almond butter, sesame sticks, and other sesame snack products; and toppings for ice cream and yogurt. The company provides its products under various private labels, as well as under the Fisher, Orchard Valley Harvest, and Sunshine Country brand na mes. John B. Sanfilippo & Son, Inc. markets its products through its own sales department, a network of independent brokers, and various independent distributors and suppliers to retailers and wholesalers, as well as to industrial, food service, and contract packaging customers. The company was founded in 1959 and is headquartered in Elgin, Illinois.
Top 10 Clean Energy Stocks To Own Right Now: Nextraction Energy Corp. (NE.V)
Nextraction Energy Corp. engages in the acquisition, exploration, development, and production of petroleum and natural gas reserves in Canada and the United States. The company holds 50% working interest in the Alexandra Provost Viking A Unit covering 2,000 net acres in east-central Alberta, and a 100% working interest in 1 section contiguous to the area; and owns 1,900 net acres along the northern extent of the Pinedale Anticline, a natural gas field, in the Green River basin of western Wyoming, the United States. It has proved plus probable reserves of 1,011 thousand barrels of oil equivalent. The company was founded in 2008 and is based in Vancouver, Canada.
No comments:
Post a Comment